Drawing for OTSUKA

USPTO serial 99009763

OTSUKA

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
FRUM MILONE, MARCIE R
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with OTSUKA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $649*

Plus Government fees of $750

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott S. Havlick

Scott S. Havlick Holland & Hart LLPP.O. Box 8749Attn: Trademark DocketingDenver, CO 80201

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; non-medicated soaps and detergents, namely, body soaps, and soaps and detergents being detergent soap for personal use; dentifrices; perfumes and colognes; false nails; false eyelashes; non-medicated soaps and detergent soaps; non-medicated toiletry preparations; facial washes; non-medicated facial soaps; non-medicated skin serums; toilet waters; non-medicated skin lotions; beauty milks; non-medicated skin creams; beauty creams for the skin around eyes; non-medicated lip care preparations; beauty masks; paper soaps for personal use; pre-moistened cosmetic tissues and wipes; make up removing preparations; make-up primers; sunblock preparations for personal use; non- medicated bath preparations; pre-moistened cosmetic towelettes for personal use; pre-moistened cosmetic towelettes impregnated with soap and deodorant for personal use; pre-moistened cosmetic towelettes impregnated with soap and detergent for personal use; tissues impregnated with cosmetics; deodorants for personal useACTIVE—
005Pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations for use as a preparatory regime in connection with bone marrow transplants; Pharmaceutical preparations for the treatment of hyponatremia, in patients with Syndrome of Inappropriate Antidiuretic Hormone (SIADH), heart failure; medical test kits for diagnosis and post treatment monitoring of infectious diseases and stomach conditions comprised primarily of a pouch of citric powder for use in making medical diagnostic reagents for measuring gas content in exhaled breath to determine existence of micro-organism in human digestive organs and medical reagents for the diagnosis and treatment of diseases in digestive organs and also containing a plastic kit tray, a "How To" guide, test instructions, a set of self-adhesive bar code stickers, breath collection bags, a sample transport bag, a plastic straw and a plastic drinking cup; Pharmaceutical preparations for the central nervous system; cardiovascular agents for treating hyponatremia, hypertension, heart failure and hypokalemia; chemotherapeutic agents; Pharmaceutical preparations for the treatment of disorders on central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing electronic chips which transmit information about drug ingestion by the patient; Pharmaceutical preparations for the treatment of polycystic kidney disease (PKD); Pharmaceutical preparations for cardiovascular diseases; Pharmaceutical preparations for the treatment of ophthalmic disorders; Chemical preparations for the treatment of diseases associated with pathogenic infections in plants; chemical preparations for reducing the symptoms associated with pathogenic infections in plants; bacteriophages for the treatment of diseases associated with pathogenic infections in plants; bacteriophages for reducing the symptoms associated with pathogenic infections in plants; plant disease treating chemicals in the nature of bacteriophages to treat plant diseases, namely, pathogenic infection; plant disease treating chemicals in the nature of bacteriophages to reduce the symptoms of plant diseases, namely, pathogenic infection; vine disease treating chemicals; bacteriophages to treat vine diseases; bactericides for use in agriculture.; Medicated shampoos; detergents for medical purposes; medicated skin oils; Pre-moistened medicated towelettes for personal use; pre-moistened medicated towelettes impregnated with soap and deodorant for personal use; pre-moistened medicated towelettes impregnated with soap and detergent for personal use; medicated soaps; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical agents for epidermis; Medicated skin serums; Medicated skin lotions; Medicated skin milk; Medicated skin creams; Medicated lip care preparations; Medicated sunburn ointments and lotions; pharmaceutical preparations for treating sunburns; Medicated bath preparations; Dietetic food adapted for medical purposes; Dietetic beverages adapted for medical purposesACTIVE—
029Soy-based nutrition food bars; soy-based meal replacement food bars; soya milk; processed soy-based foods, namely, soy jelly being jellies for food, other than confectionery; processed powdered soy beans for use in soy based snack foods; soy based snack foods; soy-based food bars and snack bars; milk products excluding ice cream, ice milk and frozen yogurt; processed vegetable and fruits; edible oils and fats, processed soy beans; food supplements not for medical purposes containing soybeans being soy-based snack foods; food supplements not for medical purposes containing proteins, fats and calcium being soy-based snack foods; food supplements not for medical purposes containing herbs, medical herbs and other plants being soy-based snack foods; food supplements not for medical purposes containing herbs, medical herbs and other plant extracts being soy-based snack foods; food supplements not for medical purposes containing plant seeds being soy-based snack foods; food supplements not for medical purposes containing sunflower oils, safflower oils, soy isoflavonoids and wheat germ oils being soy-based snack foods; food supplements not for medical purposes containing botanical extracts being soy-based snack foods; food supplements not for medical purposes containing concentrated fruits being soy-based snack foods; food supplements not for medical purposes containing maltodextrins and L-carnitines being soy-based snack foods; food supplements not for medical purposes containing milk proteins being soy-based snack foods; food supplements not for medical purposes containing whey proteins, dextrin, corn oils, apple juices, reduced dextrin and nonfat dry milks being soy-based snack foods; food supplements not for medical purposes containing extraction of components from seaweeds being soy-based snack foods; edible oils and fats; protein for human consumption in the nature of protein milk; frozen vegetables; frozen fruits; soybean milk, being a milk substitute; soup mixes; processed vegetables and fruits; fermented soybeansACTIVE—
030Tea; coffee; cocoa; jelly confectionery infused with lactic acid bacteria; bread and buns; sandwiches; pizzas; cereal preparations, namely, cereal based snack foods; instant confectionery mixes for making jelly confectionery; flour; soy snack confectionery, namely, confectionery made from soy; soy bread and buns; processed cereal preparations containing soy being soy bean paste; soy flour for food; gluten additives for culinary purposes containing soy; coffee and cocoa based beverages made with soy; confectionery containing soy flour as a main ingredient, namely, confectionery chips for baking; confectionery containing soy flour as a main ingredient, namely, pastries; soy-based bread, cookies and biscuits; soy-based processed cereals; confectionery made from soy powder, namely, confectionery chips for baking and pastries; cookies; biscuits; preparations, made from cereal, namely, cereal based snack foods; soy flour, processed cereals, soy-based ice cream substituteACTIVE—
032Sports beverages, namely, sports drinks enhanced with lactic acid bacterium and electrolytes; sports beverages, namely, sports drinks in the form of gelatins and enhanced with lactic acid bacterium and proteins; carbonated non-alcoholic drinks in the form of gelatins; powdered sports beverage mixes; carbonated non-alcoholic drinks; fruit juices; vegetable juices; beer; non-alcoholic beverages, namely, soft drinks; powdered mixes used in the preparation for making soft drinks; soy based nutritional beverages other than milk substitutes, namely, non-alcoholic carbonated beverages; non-alcoholic soft drinks made from soy powder not being milk substitutes; soy-based beverages not being milk substitutesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 30, 2026EX1GSOU EXTENSION 1 GRANTED—
Sep 30, 2026EXT1SOU EXTENSION 1 FILED—
Sep 30, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 7, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 14, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jan 14, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 14, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 14, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2025DOCKASSIGNED TO EXAMINER—
Jun 24, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 24, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 17, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance